Skip to main content Deutsch

News

New Cancer Drug Shows Exceptional Tumor-Fighting Potential

Medicine & Science

A research team led by the Medical University of Vienna, the HUN-REN Research Centre for Natural Sciences and the Eötvös Loránd University in Budapest…

Cancer Research Run 2025: 275.000 euros for cancer research

University, People of the MedUni Vienna

Thanks to this achievement, sponsors Boehringer Ingelheim, Roche, Kuehne+Nagel, and Amgen increased their support and added an additional 17.500…

Triapine: A promising approach to support cancer therapy through activation of the immune system

Medicine & Science

In a recent study, researchers at the Medical University of Vienna, in collaboration with the University of Vienna, investigated the immunostimulatory…

Researcher of the Month September 2025: Juliane Winkler

The “Researcher of the Month” jury is pleased to present this month’s award to Dr. Winkler in recognition of her recent publication in the top-tier…

Fellinger fellowship for Eva Chrenková

We are thrilled to announce that Eva Chrenková has been awarded the Fellinger Cancer Research Support for her postdoctoral project at the Center for…

New insights into how stromal cell subtypes regulate the immune system

Medicine & Science

A research team at the Medical University of Vienna led by Dietmar Herndler-Brandstetter has investigated how bone marrow niches orchestrate immune…

New study compares next-generation preclinical models for reconstructing the tumor-immune microenvironment

A research team at the Medical University of Vienna led by Dietmar Herndler-Brandstetter has investigated which next-generation preclinical models…

Colorectal cancer mortality is associated with low selenoprotein P status at diagnosis

A new study published by the research group of Andrea Gsur (Center for Cancer Research at the Medical University of Vienna) and researchers from the…

Iros Barozzi receives a Principal Investigator Project grant from the Austrian Science Fund FWF

Iros Barozzi's research project “Manipulating drivers of transcriptional heterogeneity” (PAT7184624) was approved for funding by the Austrian Science…

New findings in treatment of KRAS-mutated colorectal cancer - Study reveals surprising role for the Epidermal Growth Factor Receptor (EGFR)

University, Medicine & Science

KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat. In colon cancer, the second…